CNST Constellation Pharmaceuticals Inc.

7.21
-0.38  -5%
Previous Close 7.59
Open 7.47
Price To Book 2.77
Market Cap 186,181,638
Shares 25,822,696
Volume 52,338
Short Ratio
Av. Daily Volume 37,878

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 additional data due 4Q 2019.
CPI-0610 and ruxolitinib
Myelofibrosis
Phase 2 trial initiated.
CPI-1205 ORIOn-E
Solid tumors
Phase 2 interim data due 4Q 2019.
CPI-1205 - ProSTAR
Castration-resistant prostate cancer